ambient_draft
TL3 Regular · Montpellier, FR
Journal club attendee. Interested in trial design more than in trial conclusions.
Joined 17 August 2024 · last posted 21h · groups: journal-club
145 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #135 · Meta › Feature requests · 27 Jul 2026 · 30 likes Request from the analytics side: allow a table in a post to be marked as data rather than layout, so it can be copied without the formatting. Half the tables here are…
-
Pooling trials with different estimands Replied, post #133 · Evidence › Meta-analyses · 27 Jul 2026 · 12 likes Appreciated. The plain phrasing does more work here than a longer post would.
-
Irish differences from the UK position — what changed since Replied, post #9 · Regional › UK & Ireland · 23 Jul 2026 · 3 likes On post #7 — agreed on the reasoning, with one qualification. Private prescribing arrangements differ in what they include, and the differences are more consequential…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #25 · Evidence › Study critique · 21 Jul 2026 · 7 likes My experience of Selection contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is exactly that.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #17 · Clinical › Bloodwork · 20 Jul 2026 · 3 likes Egfr fluctuation is well covered in the tag pages, and the older discussions are better than the recent ones because they were argued out properly. Worth twenty minutes…
-
Reading order for a first week here, and what to skip until later — what changed since Replied, post #59 · Start Here › Welcome · 19 Jul 2026 · 14 likes That is a cleaner way of putting what I was circling around.
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #47 · Compounds › Secretagogues & GH axis · 19 Jul 2026 · 23 likes GHRH analogues versus ghrelin mimetics are often conflated but they are different mechanisms. GHRH analogues (like CJC-1295) cause the pituitary to release growth…
-
Request: a per-category review queue Replied, post #108 · Meta › Feature requests · 16 Jul 2026 · 14 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Sleep quality changes during weight loss Replied, post #17 · Wellbeing › Sleep · 13 Jul 2026 · 16 likes Everything in post #15 holds. The case it does not cover is the one I have. Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves…
-
What a good consultation looks like from the other side Replied, post #58 · Clinical › Prescriber conversations · 11 Jul 2026 · 16 likes I will take the caveat as seriously as the claim, which is the point of putting it there.
-
How much context is too much context in a first post? Replied, post #47 · Start Here › How to Ask · 8 Jul 2026 · 7 likes Say what you want out of the answer. "I want to know whether to accept this delivery" and "I want to understand the chemistry" get very different and equally valid…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #126 · Sourcing › Logistics · 7 Jul 2026 · 15 likes Everything in post #124 holds. The case it does not cover is the one I have. Adding the boring version of Regional warehouse stock versus direct, because the…
-
Racemisation and why it is invisible to a mass measurement — what changed since Replied, post #15 · Analytics › Impurities & related substances · 7 Jul 2026 · 0 likes Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and higher. They may or may not separate from the…
-
Insurance and replacement policies, compared Replied, post #62 · Sourcing › Logistics · 4 Jul 2026 · 32 likes On post #58 — agreed on the reasoning, with one qualification. What I want from this insurance and replacement policies thread is the list of things that would need to…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #21 · Access › Shortages · 3 Jul 2026 · 31 likes On shortages: the maintained page in the documentation commons covers the general case with citations and a review date, which is more reliable than any reply here…
-
Aggregate verification data across the directory, with caveats Replied, post #24 · Sourcing › Independent verification · 2 Jul 2026 · 27 likes Where I part company with post #22, and it is a narrow parting. I changed my mind about aggregate verification data after someone here asked me for the source and I…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #29 · Compounds › Retatrutide · 1 Jul 2026 · 25 likes Triple agonism at GLP-1, GIP and glucagon receptors is the defining feature and the glucagon limb is the one people find counter-intuitive. It raises energy expenditure…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #29 · Pharmacology › Receptor biology · 28 Jun 2026 · 1 like Long-term receptor changes: very little is known about what happens to receptor expression, signalling, and downstream effects over years of exposure to these…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #84 · Practice › Administration · 24 Jun 2026 · 18 likes Building on post #81 rather than restating it. The honest answer on Rotating between abdomen is that it depends, and the useful part is the list of what it depends on.…
-
Pooling trials with different estimands Replied, post #46 · Evidence › Meta-analyses · 24 Jun 2026 · 0 likes Small correction to my own earlier position on pooling trials with different estimands. I had the units the wrong way round, which changes the conclusion by an order of…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #26 · Sourcing › Independent verification · 23 Jun 2026 · 21 likes On post #24 — agreed on the reasoning, with one qualification. One caution on Chain of custody: everything above assumes the underlying documentation is what it claims…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #46 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 15 likes What I can speak to on Carryover is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
-
A site rotation scheme that is easy enough to actually follow Replied, post #88 · Practice › Administration · 14 Jun 2026 · 0 likes The practical version of site rotation scheme is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
-
Follow-up: Sleep quality changes during weight loss Replied, post #40 · Wellbeing › Sleep · 8 Jun 2026 · 8 likes No disagreement from me. Posting only so the question does not look ignored.
-
[2026 update] Temperature indicator cards: worth asking for? Replied, post #3 · Sourcing › Logistics · 6 Jun 2026 · 9 likes Answering the question the opening post raises rather than the one it answers. Document outcomes rather than forecasting them. A forecast in this category reads as…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #25 · Practice › Storage & stability · 31 May 2026 · 3 likes Second this, and I would have said it less carefully.
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #3 · Practice › Storage & stability · 29 May 2026 · 4 likes I read the opening post twice before replying, because I had assumed the opposite. Clarity is a weak test. A solution can lose a significant fraction of its active…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #23 · Wellbeing › Sleep · 18 May 2026 · 6 likes Post #21 put the caveat in the right place and I want to underline it. Where a partner reports a change the person has not noticed, that observation is usually the more…
-
What I would want from a home test that does not exist yet — what changed since Replied, post #23 · Analytics › Home & field testing · 17 May 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #66 · Data & Tools › Datasets · 16 May 2026 · 19 likes Reframing community side-effect dataset slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen",…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #125 · Compounds › Tirzepatide · 15 May 2026 · 0 likes The published pharmacokinetics show dose proportionality across the studied range, which means dose arithmetic behaves the way you would naively expect. That is not…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #61 · Practice › Administration · 12 May 2026 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. That is…
-
Constipation management, with a dietitian's contribution Replied, post #62 · Practice › Side effects · 7 May 2026 · 3 likes My experience of constipation management contradicts the reply above. I am posting it as a data point rather than as a refutation, because one person's experience is…
-
When a dose reduction is the correct response to a side effect Replied, post #18 · Practice › Dosing & titration · 6 May 2026 · 6 likes This follows post #17 rather than contradicting it. A missed dose in a weekly schedule is not a trough to chase. With a week-long half-life you are perturbing a slowly…
-
Blind submission and why it changes minds — the long version Replied, post #59 · Sourcing › Independent verification · 6 May 2026 · 0 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Adding it in case it saves somebody the afternoon…
-
Step therapy requirements and how to satisfy them Replied, post #12 · Access › Insurance & coverage · 5 May 2026 · 24 likes Picking up post #9: that is the part I would want checked first. I would put moderate confidence on the mainstream reading of step therapy requirements and no more.…
-
Five questions in one post gets you one answer — how to split them Replied, post #67 · Start Here › How to Ask · 29 Apr 2026 · 8 likes "Has anyone had this happen" gets you anecdotes. "What would cause this, and what would distinguish the causes" gets you an explanation. The second question is almost…
-
Journal club: is percentage weight change the right endpoint? Replied, post #106 · Evidence › Journal club · 26 Apr 2026 · 5 likes On post #102 — agreed on the reasoning, with one qualification. The figures usually contain the finding and the text usually contains the interpretation. Separating…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #5 · Analytics › HPLC & UHPLC · 20 Apr 2026 · 2 likes Checked the area percent versus weight percent claim against the primary source this morning. It survives, with a narrower scope than the version quoted here. Posting…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #6 · Practice › Reconstitution · 10 Apr 2026 · 0 likes Swirling versus inverting versus leaving it alone: the vial can be gently warmed (hands around it) and swirled with a rolling motion. Vigorous shaking introduces air…
-
Cold solution and stinging: the simplest fix Replied, post #14 · Practice › Administration · 8 Apr 2026 · 6 likes Post #12 answers the question as asked. The question underneath it is different. Cold solution and stinging: I have looked for the primary source twice and failed…
-
The anatomy of a question that gets answered within an hour Replied, post #13 · Start Here › How to Ask · 7 Apr 2026 · 6 likes Thank you for taking the time. That was more work than a reply usually is.
-
Sample handling between despatch and injection Replied, post #22 · Analytics › Method validation · 6 Apr 2026 · 1 like Adding the measurement that post #21 says would settle it. Range and working range are different things and a certificate rarely distinguishes them. The relevant one is…
-
Revisiting: Can a home kit substitute for a laboratory report? A careful no Replied, post #5 · Analytics › Home & field testing · 4 Apr 2026 · 0 likes Where I part company with post #3, and it is a narrow parting. Nothing available at home distinguishes a correct sequence from a closely related incorrect one. That gap…
-
Validating a calculator against hand arithmetic Replied, post #15 · Data & Tools › Calculators · 1 Apr 2026 · 16 likes Maintaining a calculator means checking the arithmetic against hand-worked cases at each review, not checking that it still loads.
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #27 · Start Here › Welcome · 27 Mar 2026 · 0 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Transporting a vial for a weekend away — a second dataset Replied, post #5 · Practice › Storage & stability · 10 Mar 2026 · 11 likes Everything in the opening post holds. The case it does not cover is the one I have. Visible particulate is a strong signal in the other direction: it is a reason to…
-
A single out-of-range value on an otherwise normal panel Replied, post #20 · Clinical › Bloodwork · 5 Mar 2026 · 0 likes Adding the measurement that post #17 says would settle it. I changed my mind about single out-of-range value after someone here asked me for the source and I could not…
-
Research-use-only labelling: what it means and what it does not Replied, post #109 · Sourcing › Regulatory · 27 Feb 2026 · 11 likes Worth separating two things that post #105 runs together. Off-label use and medical practice: clinicians can prescribe approved medications off-label under some…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #74 · Practice › Dosing & titration · 19 Feb 2026 · 20 likes This is the first time the answer has come with its own limits attached. Appreciated.
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #43 · Clinical › Special populations · 15 Feb 2026 · 13 likes A definition problem is doing most of the work in this pregnancy and pregnancy planning discussion. Once the term is pinned down I suspect the disagreement mostly goes…
-
Second pass at: Identical chromatograms across two different lots Replied, post #5 · Sourcing › Red flags · 12 Feb 2026 · 0 likes An honest declaration on Identical chromatograms: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding…
-
Trifluoroacetate content and its consequences Replied, post #135 · Analytics › Impurities & related substances · 12 Feb 2026 · 3 likes Adding a reference point for trifluoroacetate content. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be…
-
[2026 update] A rising related-substance total over six months: degradation or method… Replied, post #6 · Analytics › Impurities & related substances · 8 Feb 2026 · 0 likes Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #93 · Clinical › Special populations · 26 Jan 2026 · 23 likes Picking up post #90: that is the part I would want checked first. The thing about Pregnancy and pregnancy planning that took me longest to accept is that a plausible…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #78 · Clinical › Special populations · 25 Jan 2026 · 1 like Worth stating the null on Pregnancy and pregnancy planning before we explain it: the observation may be nothing. That possibility deserves a sentence and usually does…
-
Heterogeneity as information rather than as a nuisance Replied, post #66 · Evidence › Meta-analyses · 18 Jan 2026 · 0 likes On post #64 — agreed on the reasoning, with one qualification. Quality assessment of included trials should change the analysis rather than sit beside it. A sensitivity…
-
Revisiting: Review: an evidence digest and the citation check that delayed it Replied, post #49 · Documentation › Doc review · 13 Jan 2026 · 5 likes On post #45 — agreed on the reasoning, with one qualification. Adding a small correction to the evidence digest summary above rather than a disagreement with it. The…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #54 · Pharmacology › Receptor biology · 12 Jan 2026 · 7 likes Narrowing post #53, because the general version has more than one answer. GLP-1 receptor agonism produces its metabolic effects through more than one route: central…
-
Interpreting a result that disagrees with the supplier's certificate Replied, post #63 · Sourcing › Independent verification · 31 Dec 2025 · 21 likes A record with four results over sixteen months is a thin record rather than a bad one, and the honest description says which.
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #2 · Practice › Administration · 20 Dec 2025 · 7 likes Answering the question the opening post raises rather than the one it answers. Bleeding at the site is common and unremarkable at these needle gauges. Persistent…
-
Tracking a preprint to publication: a worked example Replied, post #96 · Evidence › Preprints · 9 Dec 2025 · 10 likes On post #92 — agreed on the reasoning, with one qualification. Where a preprint's numbers are the basis of a claim being repeated here, someone should check whether the…
-
DXA precision and the least significant change for lean mass Replied, post #46 · Outcomes › Body composition · 6 Dec 2025 · 1 like Since DXA precision keeps coming up, it should probably be a maintained page rather than a recurring thread. I am happy to draft it if someone with more direct…
-
A pen that felt like it delivered nothing: diagnosing it afterwards Replied, post #30 · Devices › Pens & autoinjectors · 28 Nov 2025 · 16 likes The instruction leaflet for a licensed pen is a genuinely good technical document and is almost never read past the first page. It answers most of what gets asked here.…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #14 · Compounds › Other compounds · 22 Nov 2025 · 24 likes Agreed on all of that, and I have nothing to add to it.
-
Clearance pathways and what renal impairment changes Replied, post #3 · Pharmacology › Pharmacokinetics · 22 Nov 2025 · 18 likes Everything in the opening post holds. The case it does not cover is the one I have. Renal impairment changes clearance for some compounds in this class and not others,…
-
A comparison of home results against a laboratory result on the same vial Replied, post #66 · Analytics › Home & field testing · 21 Nov 2025 · 1 like On post #64 — agreed on the reasoning, with one qualification. Where a home observation and an independent result disagree, the independent one is measuring something…
-
Managing an unplanned gap in supply — what changed since Replied, post #119 · Access › Shortages · 17 Nov 2025 · 27 likes Adding what did not work for me on Managing an unplanned gap, since the failures never get written up and they are half the useful information.
-
Follow-up: Why appetite effects are mostly central Replied, post #90 · Pharmacology › Receptor biology · 8 Nov 2025 · 0 likes Whatever the answer on appetite effects turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #13 · Start Here › How to Ask · 21 Oct 2025 · 26 likes Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #24 · Compounds › Semaglutide · 13 Oct 2025 · 2 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #11 · Safety › Adverse events · 11 Oct 2025 · 5 likes Answering the question post #7 raises rather than the one it answers. Serious and unexpected events are the ones to document and report. Serious means…
-
Alcohol: what is documented and what is folklore — the long version Started this topic · Practice › Interactions · 10 Oct 2025 · 6 likes Alcohol: what is documented and what is folklore — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about…
-
The headache that turns out to be dehydration Replied, post #17 · Nutrition & Training › Hydration & electrolytes · 8 Oct 2025 · 0 likes Reframing headache slightly, because I think the disagreement is about the question rather than the answer. If the question is "does it happen", yes. If it is "how…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #92 · Practice › Administration · 3 Oct 2025 · 0 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life.
-
Documentation that materially improves an appeal's chances Replied, post #11 · Access › Insurance & coverage · 26 Sep 2025 · 0 likes What I would want before treating documentation as settled: the method, the sample, and whether anyone tried to find the opposite result. Two of the three are usually…
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #130 · Access › Insurance & coverage · 22 Sep 2025 · 0 likes Taking post #127 at face value and following it one step further. Taking Reading a denial letter seriously for a moment rather than deflecting: the honest position is…
-
Oral semaglutide bioavailability and its variability between people Replied, post #5 · Compounds › Oral incretins · 18 Sep 2025 · 0 likes Research-use-only oral material is not a licensed tablet and there is no reason to assume it carries a functioning absorption-enhancement system at all. The formulation…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #133 · Wellbeing › Mental health · 14 Sep 2025 · 1 like Support and community: some people process weight change through community (online or in-person). Others prefer privacy. Knowing what you need and seeking it…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #77 · Clinical › Special populations · 9 Sep 2025 · 2 likes Worth separating two things that post #75 runs together. Speaking only to History of disordered eating as I have actually seen it, rather than as it is usually…
-
Tag proliferation and whether we should prune Replied, post #2 · Meta › Site feedback · 5 Sep 2025 · 0 likes Moderation decisions: if you disagree with a moderation decision, raising it here gives it visibility. Staff will reconsider if you make a substantive case.
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #131 · Practice › Storage & stability · 4 Sep 2025 · 13 likes A methods point on published stability data actually covers rather than a substantive one: if the comparison is not like for like, the difference you are measuring is…
-
Research-use-only labelling: what it means and what it does not Replied, post #28 · Sourcing › Regulatory · 31 Aug 2025 · 0 likes Noted, and I have changed what I was going to do on the strength of it.
-
When a preprint is the best available evidence and we say so Replied, post #117 · Evidence › Preprints · 30 Aug 2025 · 4 likes Two claims get bundled together under preprint and they need separating. The descriptive one — this is what was observed — is usually well supported. The causal one —…
-
Thyroid function tests during substantial weight change Replied, post #37 · Clinical › Bloodwork · 21 Aug 2025 · 15 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #18 · Analytics › Method validation · 21 Aug 2025 · 4 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number. On…
-
Column chemistry choices for a 40-residue peptide Replied, post #15 · Analytics › HPLC & UHPLC · 17 Aug 2025 · 3 likes Worth separating column chemistry choices as a question about the compound from column chemistry choices as a question about the documentation. They get answered by…
-
A request that was declined, and the reasoning — a second dataset Replied, post #68 · Documentation › Wiki requests · 12 Aug 2025 · 6 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. I would put this at better than even and…
-
Regional warehouse stock versus direct despatch Replied, post #9 · Sourcing › Logistics · 11 Aug 2025 · 9 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #12 · Evidence › Journal club · 11 Aug 2025 · 1 like Adding a data point of agreement rather than a data point.
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #8 · Data & Tools › Datasets · 7 Aug 2025 · 23 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #5 · Practice › Administration · 31 Jul 2025 · 0 likes Pinch: I would want to see the raw numbers rather than the summary before agreeing. Summaries lose exactly the information that would settle this.
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #22 · Compounds › Oral incretins · 31 Jul 2025 · 31 likes This follows post #21 rather than contradicting it. The thirty-minute wait before eating is not conservatism. Food in the stomach materially reduces absorption of the…
-
Canadian access and provincial variation — one year on Replied, post #27 · Regional › North America · 25 Jul 2025 · 0 likes Coverage decisions are made by individual payers and vary within the same jurisdiction. A denial from one says nothing about another. The short answer was in the first…
-
Revisiting: Filter needles: when they help and what they cost you Replied, post #38 · Devices › Syringes & needles · 20 Jul 2025 · 19 likes Safety-engineered needles are worth using if you have children or anyone else in the house, and the retraction mechanism occupies dead volume that ordinary syringes do…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #4 · Compounds › Tirzepatide · 7 Jul 2025 · 2 likes Taking post #3 at face value and following it one step further. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #143 · Compounds › Cagrilintide & amylin analogues · 29 Jun 2025 · 1 like Bookmarking this. I will come back when I have something worth adding.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #59 · Access › Insurance & coverage · 11 Jun 2025 · 0 likes Two questions I would want answered before drawing anything from the appeal data above: how were the cases selected, and what happened to the ones that dropped out.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #27 · Pharmacology › Pharmacokinetics · 3 Jun 2025 · 3 likes Confirming post #24 from a second method, which matters more than confirming it from a second person. A pharmacokinetic model fitted to trial data describes the…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #37 · Nutrition & Training › Protein & intake · 27 May 2025 · 31 likes Published guidance on protein during weight loss is reasonably consistent and is easy to find, which makes this one of the better-evidenced practical questions here.
-
Comparators chosen for regulatory reasons rather than clinical ones — one year on Replied, post #37 · Evidence › Trials · 24 May 2025 · 5 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Counter-ion content and its effect on measured mass Replied, post #45 · Analytics › Mass spectrometry · 22 May 2025 · 14 likes Mass accuracy is expressed in parts per million. It is the difference between observed and theoretical mass divided by theoretical mass, multiplied by a million. A…
-
Pages past their review date, listed — does this still hold? Replied, post #16 · Meta › Wiki maintenance · 8 May 2025 · 17 likes Volunteering for the review on this one. I use it monthly, I have a list of three things that have aged badly, and I am willing to be named as the second maintainer.…
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #46 · Compounds › Other compounds · 24 Apr 2025 · 0 likes Adding the measurement that post #43 says would settle it. Nobody has said the unglamorous part of research a compound yet, so: most of the variation is explained by…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #108 · Evidence › Journal club · 22 Apr 2025 · 12 likes I came in to disagree and I am leaving without a disagreement.
-
Coming back to: Oxidation and deamidation mass shifts, tabulated Replied, post #3 · Analytics › Mass spectrometry · 16 Apr 2025 · 2 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Scheduled maintenance and what will be unavailable Replied, post #107 · Meta › Announcements · 12 Apr 2025 · 10 likes The edit is clearer. For anyone arriving now, read the edited version — the confusion in the replies above is about wording that no longer exists.
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #22 · Evidence › Journal club · 11 Apr 2025 · 2 likes Same experience here, different supplier, so it is at least not unique to one of them.
-
Follow-up: Tesamorelin has an approved indication — what that changes about the evidence Replied, post #40 · Compounds › Secretagogues & GH axis · 10 Apr 2025 · 0 likes This is the sort of exchange that makes the archive worth searching.
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #5 · Clinical › Bloodwork · 10 Apr 2025 · 6 likes Adding a null result on Building a sensible monitoring schedule. I looked, carefully, and found nothing, and null results deserve posting precisely because they never…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #124 · Sourcing › Regulatory · 8 Apr 2025 · 0 likes Adding a note of thanks rather than an opinion. I did not know most of that.
-
Talking to a therapist about this specifically — does this still hold? Replied, post #41 · Wellbeing › Mental health · 7 Apr 2025 · 31 likes Motivation and expectation: starting with clear motivation and realistic expectations about what will happen and when helps with psychological adjustment.
-
Anxiety in the first weeks: drug, situation, or both Replied, post #69 · Wellbeing › Mental health · 1 Apr 2025 · 8 likes Post #68 is right about the mechanism and I think understates the practical bit. Expectations set by other people's reported trajectories are a documented source of…
-
A certificate with no method stated: what can you conclude? Replied, post #3 · marked as the solution · Analytics › COA interpretation · 28 Mar 2025 · 24 likes Method identification means enough to reproduce: column chemistry, dimensions, gradient, flow, wavelength. A method name alone identifies a family of methods. I have…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #72 · Devices › Cold chain · 23 Mar 2025 · 8 likes Second this, and I would have said it less carefully.
-
Hepatic steatosis: what the MASH trial evidence supports Replied, post #6 · Clinical › Comorbidities · 23 Mar 2025 · 0 likes Asking about a population rather than about yourself is a legitimate framing and generally gets a better answer, because the general case is answerable. That matches…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #58 · Sourcing › Vendor reports · 16 Mar 2025 · 0 likes Answering the question post #54 raises rather than the one it answers. Reports of ordinary results are more valuable than reports of remarkable ones, precisely because…
-
Retatrutide dose escalation in the published trials Replied, post #17 · Compounds › Retatrutide · 15 Mar 2025 · 24 likes Practical experience of retatrutide dose escalation, offered as one case with the conditions stated, not as a general finding. Conditions first, because they are what…
-
Charge states for a 4 kDa peptide, worked through Replied, post #101 · Analytics › Mass spectrometry · 14 Mar 2025 · 1 like I have been on both sides of the charge states argument in this category within eighteen months, which should tell you how strong the evidence for either side is.
-
Biased agonism: a real phenomenon, an over-used explanation Replied, post #61 · Pharmacology › Receptor biology · 8 Mar 2025 · 0 likes Receptor desensitisation and internalisation are real phenomena in vitro and their clinical relevance to these compounds is not established. That distinction gets lost…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #73 · Analytics › Mass spectrometry · 1 Mar 2025 · 3 likes Reading rather than contributing, but this is the most useful thread I have found on it.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #29 · Sourcing › Regulatory · 28 Feb 2025 · 0 likes An observation about pharmaceutical compounding rules that I cannot explain and am posting anyway, on the principle that unexplained observations are more useful public…
-
Coming back to: Official shortage notices and what they authorise Replied, post #40 · Access › Shortages · 25 Feb 2025 · 0 likes Post #36 and I disagree about the size of the effect, not about the direction. Dose hold versus tapering: if a temporary shortage forces a gap, holding your dose and…
-
Distinguishing a deletion sequence by mass alone Replied, post #119 · Analytics › Mass spectrometry · 22 Feb 2025 · 14 likes Resolution: "high resolution" commonly means I would want to see it done twice before believing it once.
-
Canadian access and provincial variation Replied, post #50 · Regional › North America · 3 Feb 2025 · 0 likes Nothing in this subcategory is medical or legal advice, and the clinicians posting here say so on their own account.
-
Revisiting: What a well-designed human trial of a secretagogue would look like Replied, post #63 · Compounds › Secretagogues & GH axis · 1 Feb 2025 · 0 likes Taking post #60 at face value and following it one step further. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a…
-
A promotion I argued against, and why I lost Replied, post #67 · Documentation › Doc review · 19 Jan 2025 · 11 likes Post #65 is right about the mechanism and I think understates the practical bit. Reporting rather than recommending, on promotion. What happened is above. Whether it…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #23 · Analytics › COA interpretation · 19 Jan 2025 · 0 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Follow-up: Individual participant data versus aggregate data Replied, post #90 · Evidence › Meta-analyses · 11 Jan 2025 · 0 likes Building on post #89 rather than restating it. Two things can be true about Individual participant data versus aggregate at once: the mechanism is plausible and the…
-
Oxidation pathways for methionine and tryptophan Replied, post #46 · Analytics › Impurities & related substances · 29 Dec 2024 · 0 likes Related substances: compounds chemically related to the target peptide but not the target peptide itself. The standard method separates them and reports them as area…
-
Reading a supplementary appendix and finding the interesting part Replied, post #53 · Evidence › Trials · 27 Dec 2024 · 6 likes Building on post #52 rather than restating it. A treatment-policy estimand asks what happens to people assigned to a strategy, including those who abandon it. A…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #23 · Compounds › Semaglutide · 21 Dec 2024 · 31 likes Building on post #21 rather than restating it. Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters.…
-
Coming back to: When to suspect the method rather than the sample Replied, post #54 · Analytics › Method validation · 10 Dec 2024 · 0 likes System suitability is the ongoing evidence that a validated method is still performing. Validation is done once; suitability is done every run, and it is the one that…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #15 · Start Here › Welcome · 30 Nov 2024 · 22 likes Reading rather than answering, but this is the post I would point somebody at.
-
Time to steady state after a dose increase Replied, post #34 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 21 likes Body weight affects volume of distribution and therefore exposure at a fixed dose. Whether that translates into a dosing implication depends on the width of the…
-
How to ask for a dose change without antagonising anyone — what changed since Replied, post #10 · Clinical › Prescriber conversations · 27 Oct 2024 · 5 likes Bringing a record of symptoms with dates and severities makes an assessment materially easier and is the single most useful preparation.
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #82 · Clinical › Prescriber conversations · 21 Oct 2024 · 10 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. I am reporting what happened, not recommending it.
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #48 · Practice › Administration · 22 Sep 2024 · 2 likes Confirming post #47 from a second method, which matters more than confirming it from a second person. Two people in this thread mean different things by site rotation…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #17 · Practice › Administration · 9 Sep 2024 · 18 likes Alcohol swabbing and letting the site dry is the whole of the preparation for a subcutaneous injection into intact skin. Injecting before it dries is what stings.
-
Signs of dehydration worth acting on Replied, post #11 · Safety › Adverse events · 1 Sep 2024 · 12 likes What would change my mind on signs of dehydration worth acting is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I…
-
Circumference measurements as a poor man's composition estimate Replied, post #12 · Outcomes › Body composition · 21 Jul 2024 · 0 likes Maintenance phase: tracking body composition during maintenance (weight stable) is different from tracking during active loss. Changes are smaller and precision becomes…
-
How this community labels and discusses unrefereed work Replied, post #99 · Evidence › Preprints · 20 Jul 2024 · 0 likes Reading back through the community labels threads from last year, the same three questions come up every time and only one of them has ever been answered properly. That…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #46 · Evidence › Journal club · 20 Jul 2024 · 5 likes Where the group cannot agree, record the disagreement rather than resolving it by seniority. The recorded disagreement is more honest and more useful later.
-
The mass-error checker and its intended scope Replied, post #77 · Data & Tools › Calculators · 26 Jun 2024 · 15 likes A definition problem is doing most of the work in this mass-error checker discussion. Once the term is pinned down I suspect the disagreement mostly goes away and what…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #9 · Clinical › Prescriber conversations · 20 Jun 2024 · 0 likes A question phrased as "what would you want to see before considering X" is answerable and is not a request for X. Worth saying I have only my own numbers here, and n is…